Loading organizations...
§ Private Profile · New York City, NY, USA
AI-driven digital phenotyping platform that monitors mental health conditions via passive smartphone data for clinical and corporate clients.
Based in New York City, Behavidence develops innovative artificial intelligence digital phenotyping software that analyzes passive smartphone usage patterns to detect mental health conditions like depression, anxiety, burnout, and ADHD. The organization operates a B2B SaaS model, licensing its predictive analytics platform to clinical research organizations, health insurance providers, and corporate employee wellness programs for remote clinical interventions. Operating with fewer than fifty employees, the enterprise tracks daily digital biomarkers including screen time and application interactions to generate instant diagnostic scores without requiring active user surveys or questionnaires. To support commercial expansion and enterprise platform development, Behavidence secured four million three hundred thousand dollars in seed funding from venture capital investors including Welltech Ventures and Arc Impact. The digital health company was founded in 2020 by executive leaders Roy Cohen, Girish Srinivasan, and Janine Ellenberger.
Behavidence has raised $4.3M across 1 funding round.
Behavidence has raised $4.3M in total across 1 funding round.
Behavidence has raised $4.3M across 1 funding round. Most recently, it raised $4.3M Seed in March 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 11, 2022 | $4.3M Seed | Welltech Ventures | ARC Impact, Longevity Venture Partners | Announced |
Behavidence has raised $4.3M in total across 1 funding round.
Behavidence's investors include Welltech Ventures, Arc Impact, Longevity Venture Partners.